Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Aug 2022 for La Jolla Pharmaceutical Co, €75k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Larry G. Edwards: trading record in brief
Larry G. Edwards is a declared insider of La Jolla Pharmaceutical Co (chief executive), with filings sourced from SEC (Form 4). Between 30 April 2021 and 22 August 2022, the trades on record add up to 25 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 24 August 2022: a transaction of €75k, in La Jolla Pharmaceutical Co. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Larry G. Edwards
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
11,969 shares@ US$6.2351.5% of flowCommon StockSEC:0000899243-22-029657:0
296 shares@ US$3.71451.4% of flowCommon StockSEC:0001209191-22-024635:0
334 shares@ US$3.62951.5% of flowCommon StockSEC:0001209191-22-022588:0
361 shares@ US$3.3661.6% of flowCommon StockSEC:0001209191-22-019905:0
350 shares@ US$3.47651.5% of flowCommon StockSEC:0001209191-22-014884:0
320 shares@ US$3.7911.5% of flowCommon StockSEC:0001209191-22-010874:0
4,170 shares@ US$3.935520.8% of flowCommon StockSEC:0001209191-22-006562:0
273 shares@ US$4.1821.4% of flowCommon StockSEC:0001209191-22-003890:0
233 shares@ US$3.91851.1% of flowCommon StockSEC:0001209191-22-000968:0
320 shares@ US$3.57850.9% of flowCommon StockSEC:0001209191-21-070387:0
346 shares@ US$3.3150.9% of flowCommon StockSEC:0001209191-21-067652:0
336 shares@ US$3.40850.9% of flowCommon StockSEC:0001209191-21-065160:0
335 shares@ US$3.4170.9% of flowCommon StockSEC:0001209191-21-062454:0
341 shares@ US$3.3660.9% of flowCommon StockSEC:0001209191-21-060948:0
338 shares@ US$3.39150.9% of flowCommon StockSEC:0001209191-21-059057:0
338 shares@ US$3.39150.9% of flowCommon StockSEC:0001209191-21-056670:0
320 shares@ US$3.57850.9% of flowCommon StockSEC:0001209191-21-054491:0
338 shares@ US$3.3830.9% of flowCommon StockSEC:0001209191-21-051926:0
374 shares@ US$3.06850.9% of flowCommon StockSEC:0001209191-21-049393:0
358 shares@ US$3.1960.9% of flowCommon StockSEC:0001209191-21-047250:0
315 shares@ US$3.6380.9% of flowCommon StockSEC:0001209191-21-045202:0
275 shares@ US$4.1650.8% of flowCommon StockSEC:0001209191-21-041591:0
314 shares@ US$3.6550.8% of flowCommon StockSEC:0001209191-21-037305:0
358 shares@ US$3.1960.8% of flowCommon StockSEC:0001209191-21-033822:0
304 shares@ US$3.7740.8% of flowCommon StockSEC:0001209191-21-030135:0
25 of 25 declarations
